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Differentiation Trapping Screen in Live Culture for
Genes Expressed in Cardiovascular Lineages
Weisheng V. Chen1,2 and Zhi Chen1,3,4*
We have developed a gene trap vector that transduces an EGFP-neo fusion gene (Eno) to monitor the expression of
trapped genes in living cells and embryos. Upon in vitro differentiation, most gene-trapped embryonic stem (ES) cell
clones exhibited detectable green fluorescence in various specialized cell types, which can be followed in the live
culture in real time. Populations of ES cell-derived cardiomyocytes, smooth muscle cells, vascular endothelial cells,
and hematopoietic cells were readily recognized by their distinctive morphologies coupled with unique activities,
allowing efficient screening for clones with trapped genes expressed in cardiovascular lineages. Applying G418
selection in parallel differentiation cultures further increased detection sensitivity and screening throughput by
enriching reporter-expressing cells with intensified green fluorescent protein signals. Sequence analyses and
chimera studies demonstrated that the expression of trapped genes in vivo closely correlated with the observed
lineage specificity in vitro. This provides a strategy to identify and mutate genes expressed in lineages of interest for
further functional studies. Developmental Dynamics 229:319–327, 2004. © 2004 Wiley-Liss, Inc.
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INTRODUCTION
The cardiovascular system is the first
functional organ system to form in
vertebrate embryos. The complexity
of these organogenesis events is re-
flected in the high prevalence of
congenital heart diseases, which
occur in approximately 8 of every
1,000 live births (Brown and Ander-
son, 1999). With the development of
advanced mutagenesis techniques,
particularly gene targeting, consid-
erable progress in cardiovascular re-
search has been made in recent
years. Many genes implicated in
cardiovascular development, most
notably including several transcrip-
tion factors, have been identified
and their roles validated in knockout
mice. These findings have provided
insights into the molecular mecha-
nisms governing the complicated
developmental process, as well as
the etiologies of many cardiovascu-
lar diseases (reviewed in Baldwin
and Artman, 1998; McFadden and
Olson, 2002).
Gene trapping in mouse embry-
onic stem cells is a potent mutagen-
esis tool for both gene discovery and
functional analysis. By introducing a
promoterless reporter/selectable
marker gene into the mouse ge-
nome, gene trapping efficiently dis-
rupts endogenous transcription units
largely at random and allows for
straightforward expression monitor-
ing and cloning of the trapped
genes (reviewed in Stanford et al.,
2001). In a phenotype-driven gene
trap screen (Friedrich and Soriano,
1991), we previously have estab-
lished the ROSA5 line in which tran-
scription enhancer factor 1 (TEF-1)
was disrupted. TEF-1 null embryos die
around E11.5 with thin ventricle walls
and impaired trabeculation, sug-
gesting its essential role in cardio-
genesis (Chen et al., 1994). A similar
screen identified the transcription
factor Jumonji as a critical player for
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neural tube formation, hematopoie-
sis, and cardiac development
(Takeuchi et al., 1995, 1999; Kitajima
et al., 1999). Alternatively, expres-
sion-driven gene trap screens can
be conducted to find lineage-spe-
cific genes by generating chimeric
embryos with trapped clones and
examining the reporter expression
patterns (Wurst et al., 1995). Al-
though exceedingly informative, in
vivo gene trap screens are labor-in-
tensive and require vast resources.
Taking advantage of the develop-
mental potential of embryonic stem
(ES) cells to differentiate into a vari-
ety of cell types under appropriate
culture conditions (reviewed in
Keller, 1995; O’Shea, 1999), several
differentiation trapping methods
have been developed to preselect
gene trap events in vitro (Shirai et al.,
1996; Baker et al., 1997; Muth et al.,
1998; Stanford et al., 1998; Cannon
et al., 1999; Hidaka et al., 2000). By
using morphologic criteria and/or
immunolabeling with lineage-spe-
cific antibodies, these approaches
attempted to predict if the trapped
gene is expressed in certain lineages
in the mouse by identifying the re-
porter-expressing cell types derived
from the corresponding trapped
clone. Although limited information
on spatial–temporal expression pat-
terns can be obtained, these meth-
ods significantly enrich for clones
with trapped genes expressed in the
lineages of interest. The power of dif-
ferentiation trapping screens was
well demonstrated in the rediscov-
ery of jumonji based on its expression
in ES-cell derived cardiomyocytes,
which faithfully reflects the in vivo
myocardium expression (Baker et
al., 1997; Lee et al., 2000).
The cardiovascular lineages are
among the most recognizable cell
types in the complex embryonic
stem (ES) cell differentiation culture.
In addition to the specialized struc-
tures they form, these cells exhibit
characteristic activities that are hall-
marks for lineage identification. The
most striking activities are the spon-
taneous, rhythmical contractions of
cardiomyocyte aggregates (Wobus
et al., 1991). Smooth muscle cells are
found in tightly packed bundles of
thin fibers showing slow, wave-like
contractions (Weitzer et al., 1995;
Drab et al., 1997), which differ mark-
edly from the much thicker, fast-
contracting skeletal muscle myo-
tubes (Rohwedel et al., 1994).
Vascular endothelial cells form
blood island-like pockets and blood
vessel-like channels that frequently
contain slowly moving or flowing he-
matopoietic cells, which are round
and refractile in appearance (Wang
et al., 1992; Bautch et al., 1996).
However, morphologic identification
of cardiovascular lineages, especially
of cardiomyocytes, is challenging
with conventional differentiation trap-
ping screens where -galactosidase is
predominantly used as gene trap re-
porter, as these cellular activities are
abolished after fixation as required for
X-Gal staining. Although lineage iden-
tities can be unambiguously revealed
with immunocytochemistry, this ap-
proach is rather laborious, and would
need multiple replicates to label dif-
ferent cell types. Moreover, because
the differentiation culture is highly het-
erogeneous and dynamic, screening
at one end point may miss genes ex-
pressed in certain lineages that are
either absent or unidentifiable at the
time of sampling. To circumvent these
obstacles, we have developed a
gene trap vector that uses green flu-
orescent protein as a noninvasive re-
porter for differentiation trapping
screens in live culture.
RESULTS AND DISCUSSION
Construction of a Green
Fluorescent Neomycin
Phosphotransferase
A human codon-optimized green
fluorescent protein variant EGFP
(Clontech) was fused in-frame to the
neomycin phosphotransferase (neo)
gene to create a reporter/select-
able marker hybrid, Eno (for EGFP-
neo), in the same manner as previ-
ously described for geo (Friedrich
and Soriano, 1991). To determine
whether the GFP activity is compro-
mised in the fusion protein, expres-
sion vectors with EGFP, Eno, or a
commercially available fusion Neo-
EGFP (Clontech) placed under the
controls of the phosphoglycerate ki-
nase 1 (PGK) promoter and the bo-
vine growth hormone polyadenyla-
tion signal (bpA) were constructed.
Transient expression in NIH3T3 cells in-
dicated that the GFP signal intensity
of Eno was only slightly weaker than
that of EGFP, yet considerably stron-
ger than that of NeoEGFP. To test the
functionality of the neo moiety of the
fusion protein, PGKEnobpA was elec-
troporated into ES cells in parallel with
PGKgeobpA. Similar numbers of
G418 resistant clones were obtained,
and virtually every PGKEnobpA clone
emitted robust green fluorescence.
Therefore, Eno encodes a bifunctional
protein with both GFP and neo activ-
ities, neither of which is significantly im-
paired in the fusion.
Establishment of Differentiation
Culture Conditions Suitable for
Cardiovascular Lineage
Formation
To set up the in vitro differentiation
conditions that favor the formation
of cardiovascular lineages, particu-
larly cardiomyocytes, we first com-
pared two methods for embryoid
body (EB) induction: the suspension
culture and the hanging drop cul-
ture. The induced EBs were trans-
ferred to gelatin-coated 24-well
plates to allow attachment. EBs
formed in the suspension culture var-
ied vastly in size and shape and
tended to aggregate with each
other. As a result, many EBs were un-
able to attach or to outspread, and
secondary cystic EBs were fre-
quently formed. Although multiple
EBs (n  10) were seeded into each
well, only half of the wells contained
spontaneously contracting areas
during 20 days of differentiation,
most of which appeared after day
12 (i.e., 8 days after plating). In sharp
contrast, the hanging drop culture
reproducibly yielded EBs with similar
size and regular shape, most attach-
ing onto gelatinized surface over-
night and forming nice outgrowths.
Rhythmical contractions were ob-
served in around one third of individ-
ual EB outgrowths on as early as day
7, and the majority of wells con-
tained multiple beating foci by day
14. To examine the representation of
cardiovascular lineages in these cul-
tures, we performed indirect immu-
nofluorescence staining on day 20
EB outgrowths by using antibodies
against sarcomeric myosin heavy
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chain (Bader et al., 1982), smooth
muscle -actin (Skalli et al., 1986),
and PECAM-1/CD31 (Vecchi et al.,
1994). Besides abundant cardiomy-
ocytes (Fig. 1A), populations of
smooth muscle cells (Fig. 1B,C), vas-
cular endothelial cells, and hemato-
poietic cells (Fig. 1D–F) were also fre-
quently observed, suggesting that
the hanging drop culture is the
method of choice to promote the
formation of a full spectrum of car-
diovascular lineages.
Expression of Eno Under
-Cardiac Myosin Heavy
Chain Promoter
To mimic a gene trap event in a car-
diac-specific gene and examine the
behavior of Eno in the differentiation
culture, the fusion gene was placed
downstream of -cardiac myosin
heavy chain (MHC) promoter (Klug
et al., 1996), and a PGK-hygro cas-
sette was incorporated in the vector
to derive stable transfectants. After
electroporation and hygromycin se-
lection, resistant ES cell colonies were
pooled, expanded, and induced to
differentiate in the hanging drop cul-
ture followed by the attachment cul-
ture. Starting on day 14, G418 selec-
tion was applied in one duplicate and
maintained for 10 days. Although
green fluorescent beating foci were
readily observed in unselected EB out-
growths, the GFP signals were typi-
cally weak (Fig. 2A,D). In contrast, the
10-day selection eliminated most cells
in culture, and masses of rhythmically
contracting cells with strong green flu-
orescence (Fig. 2B,E), as well as indi-
vidual green fluorescent cells with
contractility (Fig. 2C,F) were ob-
served, indicating the accumulation
of Eno proteins within these cells.
These observations suggested that ex-
pression of the fusion gene is strictly
controlled by the acquired regulatory
elements and that applying G418 se-
lection in the differentiation culture
can enrich for reporter-expressing
cells with intensified GFP signals.
Therefore, this pilot experiment pro-
vided the proof-of-principle and
guidelines for differentiation trapping
screens in live culture by using an Eno-
based vector.
Differentiation Trapping Screen
The gene trap vector SAEnobpA
was constructed by replacing geo
in SAgeobpA (Friedrich and Sori-
ano, 1991) with Eno, and gene-
trapped clones were obtained with
electroporation followed by G418
selection. Because capturing an en-
dogenous promoter is absolutely re-
quired to activate Eno expression,
essentially every G418 resistant
clone represents a gene trap event
(Fig. 3A). Of the 118 trapped clones
isolated, 116 clones emitted green flu-
orescence of markedly different in-
tensities as assayed at passage 2 (Fig.
3B,C), reminiscent of the high per-
centage of -galactosidase–positive
clones obtained with SAgeobpA or
its retroviral version ROSAgeobpA.
This finding was due to a mutation in
the neo moiety that reduces its sensi-
tivity (Komada et al., 2000), so that
most trapped genes are expressed at
relatively high levels in ES cells. As seen
with geo-based gene traps intro-
duced by either electroporation or
retroviral infection, in some clones, the
GFP fluorescence displayed a mosaic
pattern, suggesting that the clonal
heterogeneity in reporter expression is
reporter independent.
For the differentiation trapping
screen, a 96-format hanging drop
culture was designed to facilitate
Fig. 1. Representation of cardiovascular lineages in the differentiation culture. Embryoid bodies (EBs) were formed in the hanging drop
culture and transferred to gelatinized chamber slides for attachment. EB outgrowths were assayed on day 20 by indirect immunofluo-
rescence staining with lineage-specific primary antibodies. A: Cardiomyocytes were labeled with the sarcomeric myosin heavy chain
mAb MF-20, which also recognizes skeletal muscle cells (not shown). B,C: Individual (B) or bundles (C) of smooth muscle cells were usually
found in the periphery or the center of EB outgrowths, respectively (smooth muscle -actin mAb 1A4). The PECAM-1/CD31 mAb labels
vascular endothelial cells and certain hematopoietic cells. D: Blood-vessel-like channels lined by vascular endothelial cells. E: A blood
island-like structure surrounded by vascular networks. F: A hematopoietic cell colony with strong PECAM-1/CD31 staining.
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the manipulation of multiple clones.
The formed EBs were subsequently
transferred into duplicate 24-well
plates for attachment cultures (Fig.
3D,E), and G418 selection was ap-
plied to one set after day 14. With
Eno as a vital reporter, we were able
to monitor the expression of trapped
genes at desired stages throughout
the entire culture period. Although a
general reduction in signal intensity
was observed after differentiation,
the majority of trapped clones con-
tinued to exhibit detectable green
fluorescence in a variety of deriva-
tive cell types. While most cell types
were morphologically indistinguish-
able, aggregates of beating cardio-
myocytes, contracting smooth mus-
cle cell bundles, as well as blood
vessels and blood islands comprising
Fig. 2. Expression of MHC-driven Eno in embryonic stem (ES) cell-derived cardiomyocytes. Embryoid body (EB) outgrowths from
transfected ES cells were either selected with G418 on day 14 for 10 days or kept unselected. A,D: Green fluorescence was readily detected
in beating areas in the unselected culture, but the signal intensity was typically weak. B,C,E,F: G418 selection eliminated most cells in EB
outgrowths, and much stronger GFP signals were observed in the remaining contractile cell masses (B,E) as well as individual cardio-
myocytes (C,F), indicating the accumulation of Eno proteins under selection.
Fig. 3. Gene trapping with SAEnobpA and Eno expression in embryonic stem (ES) cells and embryoid bodies of gene-trapped clones.
A: The gene trap vector was constructed by placing a promoterless Eno downstream of an adenoviral splice acceptor (SA) and upstream
of the bovine growth hormone polyadenylation signal (bpA). Upon integration into an intron of an endogenous gene, the 5 exons were
forced to splice into the introduced gene trap to generate a fusion transcript, from which Eno can be expressed independently or as a
fusion protein depending on the insertion position. As a result, the endogenous transcription is arrested. B: A gene-trapped ES cell clone
showing a medium level of green fluorescence. C: ES cell colonies of the same clone at passage 2. D: A day 4 EB formed in the hanging
drop culture. E: EB outgrowths formed 1 day after plating. Note the characteristic yellow autofluorescence from dead cells.
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vascular endothelial cells and mov-
ing hematopoietic cells were readily
identified by their characteristic
structures and activities. This identifi-
cation allowed us to screen for
clones in which the trapped genes
are expressed in the cardiovascular
lineages (Fig. 4A–L). Among other
lineages, contractile skeletal muscle
myotubes were the most prominent
(Fig. 4M,N). Consistent with the
above observations on the behavior
of MHC-driven Eno, the expression
in the same lineage was evident in
both selected and unselected cul-
tures in some cases, whereas the
green fluorescence was always re-
markably brighter in the selected
culture (Fig. 4A–H). In many clones,
the GFP signals in certain lineages
were only detectable in the se-
lected culture; these signals would
have been missed if only unselected
cultures were set up. Therefore, ap-
plying G418 selection significantly in-
creased detection sensitivity and
screening throughput. However, a
drawback of the selection procedure
was that no cells survived in some
cases, presumably due to diminished
Eno expression upon differentiation, or
the deprival of supporting cell layers
underneath expressing cells. Occa-
sionally, undifferentiated ES cells were
also enriched, which could form enor-
mous colonies that dominate the cul-
ture. Together, these two scenarios
resulted in uninformative selected cul-
tures in approximately 30% of trapped
clones, for which only the unselected
cultures were examined for reporter-
expressing cell types.
Of the 118 clones screened, we
identified a total of 18 clones that
showed detectable GFP signals in
beating cardiomyocyte nests. In 35
clones, green fluorescence was ob-
served in blood vessel-like or blood is-
land-like structures, indicating the ex-
pression of trapped genes in vascular
endothelial cells and/or hematopoi-
etic cells. Eno-positive smooth muscle
cells or skeletal muscle cells were
found in only a few clones, which was
apparently associated with the low
occurrence of identifiable popula-
tions of these cells in the culture. Ap-
plying specialized differentiation cul-
ture conditions (Rohwedel et al., 1994;
Drab et al., 1997) or conducting the
screen in a larger format may be
needed to increase the throughput
for genes expressed in these lineages.
Fig. 4. Differentiation trapping screen in live culture. Embryoid body (EB) outgrowths of gene-trapped embryonic stem (ES) cell clones were
cultured in the presence or absence of G418 and observed for Eno-expressing cell types. Shown are unselected (A,B,E,F) or selected (C,D,G–N)
EB cultures of representative clones with Eno expression in lineages identifiable with their characteristic morphologies and activities. Detection
sensitivity and screening throughput were significantly increased with G418 selection. A–D: Beating cardiomyocyte aggregates (arrows). E–H:
Contracting smooth muscle cell bundles. In both cases, the GFP signals were evidently stronger in the selected culture (C,D,G,H) compared with
the unselected culture (A,B,E,F) of the same clone. I,J: A blood vessel with Eno expression in vascular endothelial cells. K,L: A blood island with
Eno expression in hematopoietic cells. M,N: Eno-positive contractile skeletal muscle myotubes. O,P: An embryonic day 11.5 chimeric embryo
(right) produced with clone CC1B11 (shown in A–D) and a wild-type littermate (left). Green fluorescence was detected in the heart (arrows) and
the liver (arrowheads) in the chimeric embryo. Forelimbs were removed to facilitate visualization.
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Cloning of Candidate Cardiac
Genes and Correlation
Between In Vitro and In Vivo
Expression
For all of the 18 clones with trapped
candidate cardiac-expressing genes,
green fluorescent beating foci were
observed after 10 days under selec-
tion, although the signal intensity
varied vastly between clones. Anti-
body staining with MF-20 in three se-
lected clones further confirmed GFP
expression in labeled cardiomyo-
cytes (not shown). To assess in vivo
expression patterns of trapped
genes, chimeric embryos were gen-
erated from five clones and exam-
ined at E11.5. As expected, all three
lines with detectable green fluores-
cence showed expression in the
heart (Fig. 4O,P). The absence of
GFP signals in the remaining two lines
might be due to low chimerism or
low expression levels at this stage.
We performed 5-rapid amplifica-
tion of cDNA ends (RACE) on 10
clones and obtained informative
trapped sequences from seven
clones (Table 1). In five clones, the
trapped sequence matched a
known or predicted protein-coding
gene. For the four genes with Uni-
Gene cluster available, multiple cor-
responding expressed sequence
tags (ESTs) isolated from heart or car-
diac muscle cDNA libraries were
found in each cluster, indicating the
expected heart expression in vivo.
Among these, the UniGene cluster
for hypoxia-induced gene 1 (hig1)
contains the highest number of car-
diac ESTs (n  15). Hig1 was originally
identified with microarray analyses
as upregulated by hypoxia in normal
and cancerous human cervical ep-
ithelial cells (Denko et al., 2000) as
well as in mouse cerebral cortical
neurons (Jin et al., 2002). Given the
cardiac expression of HIG1 and its
potential localization in mitochon-
dria (Denko et al., 2000), it is appeal-
ing to investigate its involvement in
cardiomyocyte apoptosis, a main
cause of hypertensive heart dis-
eases known to be inducible by hyp-
oxia (Fortuno et al., 2001). Remark-
ably, two of these genes (trapped in
clone CC1C5 and clone CC2E4) en-
code for putative transcription fac-
tors, and one gene (Stag1) encodes
for a member of a novel family of
nuclear proteins (Carramolino et al.,
1997). With the availability of the
trapped clones, mutant mice could
be directly generated to study their
potential roles in cardiogenesis and
other developmental processes.
The ubiquitously expressed mouse
45S pre-ribosomal RNA gene (rDNA)
was trapped in clone CC1B5. This
finding might have resulted from the
relatively higher levels of rDNA ex-
pression in beating cardiomyocytes
in the differentiation culture, as ac-
celerated rDNA transcription is re-
quired for cardiac growth and hy-
pertrophy (Brandenburger et al.,
2001). Nonetheless, due to the com-
plexity of the differentiation culture
and the mosaic patterns of reporter
expression, ubiquitous genes cannot
be reliably ruled out in differentiation
trapping screens (Baker et al., 1997;
Stanford et al., 1998; Hidaka et al.,
2000). The trapped sequence of
clone CC1B11 matched multiple
genomic DNA fragments from differ-
ent chromosomes and over 500
mouse ESTs with a cutoff expect
value  1025, suggesting that it is a
repetitive element present in many
transcripts. RepeatMasker search-
ing (http://repeatmasker.genome.
washington.edu/) revealed that it
belongs to the endogenous retrovi-
rus-like (ERV-L) repeat family (Benit et
al., 1999). Of interest, restricted GFP
expression pattern was observed in
chimeric embryos of this clone (Fig.
4O,P), consistent with the observa-
tions that expression of some endog-
enous retroviruses is developmen-
tally regulated (Schon et al., 2001).
The identity of the trapped gene is
yet to be defined in further studies.
Together, chimera studies and se-
quence analyses provided evi-
dence on heart expression for most
candidate cardiac clones exam-
ined, manifesting that expression of
the trapped genes in the mouse
faithfully recapitulated the observed
lineage specificity in culture.
In summary, we have developed
an Eno-based vector system for dif-
ferentiation trapping screens in live
culture, which is particularly useful
for identifying genes expressed in
the cardiovascular lineages that
form specialized structures and ex-
hibit characteristic cellular activities.
This approach significantly facilitates






cluster Cardiac ESTs/Total ESTs
CC1B5 Mouse 45S pre-ribosomal RNA gene X82564
CC1B11 Repeat, ERV-L family
CC1C5 RIKEN cDNA 6820402O20 gene; transcription
factor TZP homolog [Homo sapiens]
NM_172674 Mm.18898 2/313
CC1F10 Hypoxia-induced gene 1 (Hig1) NM_019814 Mm.7381 15/307
CC1G5 RIKEN cDNA 6720485C15 gene NM_026551 Mm.181633 3/237
CC2E4 Hypothetical protein C530030I18; similar to zinc
finger protein FLJ10697 [Homo sapiens]
XM_283507
CC2E5 Stromal antigen 1 (Stag1) NM_009282 Mm.42135 2/150
aNumbers of cardiac ESTs and total ESTs of each UniGene cluster were based on UniGene Build #120. EST, expressed sequence
tag.
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lineage identification compared
with using morphologic criteria only
and is more efficient and cost-effec-
tive than performing immunostain-
ing with lineage-specific antibodies.
Moreover, the use of GFP as gene
trap reporter permits continuous ex-
pression monitoring in the dynamic
differentiation culture without the
need of making multiple replicates
for timed samplings, thereby further
increases the screening throughput.
Clearly, this system can be exploited
to identify genes expressed in other
lineages with suitable differentiation
culture conditions, as well as genes
responsive to exogenous stimuli with
standard induction trapping meth-
ods (Forrester et al., 1996; Komada
et al., 2000) or fluorescence acti-
vated cell sorting (Whitney et al.,
1998; Medico et al., 2001).
EXPERIMENTAL PROCEDURES
Vector Construction
The EGFP coding sequence was
amplified from pEGFP-1 (Clontech)
by using primers 5-GAAGATCTTC-
CACCGGTCGCCACCATG-3 and
5-GAAGATCTTGTACAGCTCGTC-
CATGCC-3 to introduce a BglII site
on both ends. The BglII–BglII frag-
ment was used to replace the
BamHI–BamHI gal fragment in
PGKgeobpA (Friedrich and Soriano,
1991) to derive PGKEnobpA. To con-
struct PGKEGFPbpA, PGKgeobpA
was first digested with SmaI and XbaI
to remove geo, blunted with T4 DNA
polymerase, ligated to an NheI linker
and then digested with Nhe I, fol-
lowed by inserting an EGFP fragment
modified in the same manner. PGK-
NeoEGFP was constructed by replac-
ing the NheI–NheI EGFP fragment in
PGKEGFPbpA with the NheI–XbaI
NeoEGFP fragment from pNeoEGFP
(Clontech). To derive MHC-Eno/
PGK-hygro, an SpeI–SmaI (partial)
EnobpA fragment was released from
PGKEnobpA, blunted, and cloned
into MHC-neo/PGK-hygro (Klug et
al., 1996) by using a NotI linker to re-
place the NotI–NotI neo-pA fragment.
To engineer the gene trap vector
SAEnobpA, the SpeI–SmaI (partial)
EnobpA fragment was subcloned into
pBluescript KS II, excised on a HindIII-
XbaI fragment, and used to replace
geobpA in SAgeobpA.
Cell Culture and Transfection
NIH3T3 cells were maintained in
DMEM supplemented with 10% fetal
calf serum, 50 U/ml penicillin, and 50
g/ml streptomycin. Equal molar
amounts of PGKEnobpA, PGKEGF-
PbpA, and PGKNeoEGFPbpA were
used to transfect the cells by using
Lipofectamine-plus reagents (Invitro-
gen). Relative GFP signal intensity for
each construct was assessed by the
average exposure time of 10 repre-
sentative fields. AK7.1 ES cells (Sori-
ano, 1997) were cultured in DMEM
supplemented with 15% fetal bovine
serum, 50 U/ml penicillin, 50 g/ml
streptomycin, and 0.1 mM 2-mercap-
toethanol on mitomycin C-treated
SNL (neor; McMahon and Bradley,
1990) or SNLH (neor/hygror) feeder
cell layers. ES cells were electropo-
rated with linearized plasmids and se-
lected in appropriate antibiotics (200
g/ml G418 or 200 g/ml hygromycin
B) for 10–12 days to derive resistant
clones. PGKgeobpA, PGKEnobpA,
and MHC-Eno/PGK-hygro were lin-
earized with XhoI, and SAEnobpA with
ScaI.
In Vitro Differentiation
Embryoid body (EB) induction in the
suspension culture (Stanford et al.,
1998) or the hanging drop culture
(Wobus et al., 1991) was carried out
essentially as described, except that
30-l drops containing 800–1,000
cells were set up and that standard
ES cell medium was used. Resulting
EBs were transferred in groups (if
formed in the suspension culture) or
individually (if formed in the hanging
drop culture) into gelatin-coated 24-
well plates on day 4 for subsequent
attachment cultures. For the differ-
entiation trapping screen, the hang-
ing drop culture method was modi-
fied to form EBs in a 96-format. Briefly,
gene-trapped ES cell clones were
grown to confluence in 96-well
plates, trypsinized, and reduced to a
single cell level by vigorous pipet-
ting. Serial dilutions were then made
in 96-well plates to adjust the cell
density to 3  104/ml, based on the
cell counts of representative wells.
Drops of 30-l ES cell suspension
were evenly arrayed on the lid of a
U-bottom 96-well plate by using a
multiple channel pipettor, and the
lid was carefully inverted and
placed over the bottom of the 96-
well plate preloaded with 10 ml of
PBS. The assemblies were left un-
touched in the incubator for 4 days,
and the resultant EBs were then
transferred into gelatinized 24-well
plates. For each clone, 6 EBs were
produced for duplicate attachment
cultures, with 3 EBs per well. To enrich
for reporter-expressing cells, G418
selection (200 g/ml) was applied in
one set of differentiation cultures on
Day 14 after EB induction and main-
tained for 10 to 20 days. Medium
was changed every 2–3 days for the
first 10 days and when needed
thereafter.
Chimera Production
ES cells were microinjected into
C57BL/6J blastocysts to generate
chimeric embryos according to
standard procedures.
Immunocytochemistry
EB outgrowths cultivated on chamber
slides were fixed in 4% paraformalde-
hyde for 10 min, followed by a 30-min
treatment in 0.3% Triton X-100 and 10%
goat serum in PBS. Treated cells were
incubated for 1 hr with antibodies
against sarcomeric myosin heavy
chain (MF-20), smooth muscle -actin
(1A4), or PECAM-1/CD31 in 10% goat
serum. Primary antibodies were de-





GFP fluorescence of living cells was
observed under an inverted Zeiss
epifluorescence microscope using a
standard fluorescein isothiocyanate
filter, and images were recorded on
Kodak P1600 films. To reduce
autofluorescence, growth medium
was replaced with warm Ca		/
Mg		-containing HBSS (Invitrogen)
just before observation. Chimeric
embryos were placed in PBS and
observed under a dissecting micro-
scope equipped with an epifluores-
cence condenser and a GFP filter.
Images were acquired with a digital
Kalman averaging filter to reduce
random noise.
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Cloning Trapped Genes by 5-
RACE
The 5-RACE was performed as de-
scribed (Hildebrand and Soriano,
1999) by using total RNA extracted
from gene-trapped ES cell clones.
The gene-specific primers used were
as follows: EnoR1, 5-GATGGGGGT-
GTTCTGCTGGTAGTGG-3; EnoR2, 5-
GAAGATGGTGCGCTCCTGGACG-
TAG-3; and EnoR3, 5-CTTCAGG-
GTCAGCTTGCCGTAGGTG-3. RACE
products were cloned into the
pGEM-T Easy vector (Promega) and
sequenced with a splice acceptor
exon-specific primer SAER 5-GAAA-
GACCGCGAAGAGTTTG-3.
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